CN Stock MarketDetailed Quotes
688105 Nanjing Vazyme Biotech
- 18.82
- -0.26-1.36%
Market Closed Sep 10 15:00 CST
7.53BMarket Cap285.15P/E (TTM)
19.10High18.42Low7.48KlotVolume18.99Open19.08Pre Close13.96MTurnover0.45%Turnover RatioLossP/E (Static)400.01MShares41.3952wk High1.91P/B3.16BFloat Cap17.4852wk Low22.90Limit Up167.86MShs Float128.85Historical High15.26Limit Down3.56%Amplitude17.48Historical Low0.10Dividend TTM18.67Avg Price3.84KlotAsk0.53%Div YieldTTM100Lot Size3.31KlotBid
Nanjing Vazyme Biotech Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -47.34%528.52M | -57.32%246.79M | -49.24%1.68B | -38.97%1.28B | -35.71%1B | -39.62%578.21M | 79.79%3.3B | 77.06%2.09B | 79.70%1.56B | 85.05%957.7M |
| Refunds of taxes and levies | ---- | ---- | -68.95%8.01M | -52.96%8.01M | -84.01%1.87M | ---- | --25.78M | --17.02M | --11.71M | ---- |
| Cash received relating to other operating activities | 23.84%57.36M | 93.51%27.6M | 235.34%162.98M | 114.44%70.73M | 52.12%46.32M | -16.71%14.26M | 109.36%48.6M | 247.23%32.99M | 264.50%30.45M | 327.02%17.13M |
| Cash inflows from operating activities | -44.29%585.88M | -53.69%274.39M | -45.30%1.85B | -36.72%1.36B | -34.40%1.05B | -39.22%592.48M | 81.54%3.38B | 79.84%2.14B | 82.79%1.6B | 86.91%974.83M |
| Goods services cash paid | -35.16%165.66M | -61.80%68.57M | -68.95%381.73M | -67.73%322.56M | -69.68%255.48M | -66.42%179.5M | 210.20%1.23B | 238.17%999.51M | 287.92%842.57M | 430.00%534.54M |
| Staff behalf paid | -30.03%342.94M | -31.88%195.49M | 4.79%813.37M | 20.70%628.97M | 48.13%490.12M | 63.12%286.99M | 107.15%776.17M | 111.39%521.11M | 124.51%330.88M | 113.60%175.94M |
| All taxes paid | -55.70%33.72M | -86.79%13.84M | -37.53%107.77M | -41.98%96.84M | -27.75%76.12M | 125.01%104.74M | -1.80%172.5M | 19.22%166.92M | 17.84%105.35M | -6.66%46.55M |
| Cash paid relating to other operating activities | -36.41%117.81M | -40.15%77.99M | -15.77%392.62M | -0.38%326.3M | -4.16%185.25M | -10.16%130.32M | 56.44%466.13M | 55.82%327.55M | 68.28%193.29M | 180.99%145.06M |
| Adjustment items of operating cash outflws | ---- | ---- | ---- | --0.01 | ---- | ---0.01 | ---- | ---- | ---- | ---- |
| Cash outflows from operating activities | -34.44%660.13M | -49.27%355.89M | -35.88%1.7B | -31.78%1.37B | -31.60%1.01B | -22.23%701.55M | 112.44%2.64B | 125.83%2.02B | 158.78%1.47B | 216.83%902.1M |
| Adjustment items of net operating cash flow | ---- | ---- | ---- | --0.01 | ---- | ---0.01 | ---- | ---- | ---- | ---- |
| Net cash flows from operating activities | -265.84%-74.25M | 25.28%-81.5M | -79.19%152.99M | -114.54%-18.59M | -65.85%44.77M | -249.97%-109.07M | 19.19%735.17M | -57.28%127.86M | -57.46%131.1M | -69.29%72.73M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 43.29%3.47B | 12.87%1.45B | -42.71%5.28B | -50.27%3.38B | -46.90%2.42B | -15.20%1.29B | 73.62%9.21B | 83.03%6.79B | 46.66%4.56B | -12.59%1.52B |
| Cash received from returns on investments | 11.30%19.85M | -11.39%7.57M | -26.39%45.42M | -35.94%30.37M | -45.13%17.83M | -18.29%8.54M | 135.96%61.7M | 201.94%47.41M | 230.28%32.5M | 228.19%10.45M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -74.92%1.3M | --1.13M | -13.50%13.48M | 11.93%9.52M | -32.12%5.19M | ---- | 471.78%15.59M | 425.61%8.5M | 637.64%7.64M | ---- |
| Cash received relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Cash inflows from investing activities | 42.81%3.49B | 12.79%1.46B | -42.55%5.34B | -50.09%3.42B | -46.86%2.44B | -15.22%1.3B | 74.12%9.29B | 83.68%6.84B | 47.43%4.6B | -12.18%1.53B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -75.67%42.27M | -68.60%29.66M | -75.81%232.9M | -68.61%240.61M | -71.71%173.72M | -74.87%94.47M | 267.56%962.86M | 254.31%766.6M | 324.19%613.98M | 503.11%375.97M |
| Cash paid to acquire investments | 29.55%2.9B | -45.57%956.83M | -34.46%6.01B | -38.52%4.08B | -51.91%2.24B | -5.43%1.76B | 40.92%9.16B | 67.80%6.64B | 44.00%4.66B | -3.88%1.86B |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | --117.93M | --163.87M | ---- | ---- |
| Cash outflows from investing activities | 21.98%2.94B | -46.75%986.49M | -39.10%6.24B | -42.90%4.33B | -54.22%2.41B | -17.11%1.85B | 51.44%10.24B | 81.39%7.57B | 56.00%5.27B | 11.95%2.23B |
| Net cash flows from investing activities | 1,654.44%547.43M | 185.97%477.06M | 5.44%-900.65M | -24.59%-909.43M | 104.65%31.2M | 21.23%-554.93M | 33.31%-952.44M | -62.37%-729.95M | -159.26%-671.15M | -177.75%-704.52M |
| Financing cash flow | ||||||||||
| Cash from borrowing | -49.33%564.5M | -25.69%539.5M | 292.74%1.46B | 362.60%1.39B | --1.11B | --726M | --372M | --300M | ---- | ---- |
| Cash received relating to other financing activities | ---- | ---- | --555.35K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | -49.33%564.5M | -25.69%539.5M | 292.89%1.46B | 362.60%1.39B | --1.11B | --726M | -82.53%372M | --300M | ---- | ---- |
| Borrowing repayment | 417.85%1.25B | --809.45M | 308.41%638.79M | 341.18%441.18M | 2,947.30%241.18M | ---- | 295.41%156.41M | 303.13%100M | -51.58%7.91M | ---- |
| Dividend interest payment | -96.55%17.73M | 165.73%7.9M | 303.31%533.33M | 330.18%523.53M | 327.34%514.59M | --2.97M | 2,874.87%132.24M | 4,461.74%121.7M | 6,582.96%120.42M | ---- |
| Cash payments relating to other financing activities | 584.16%100.5M | --56.89M | 821.43%39.64M | --14.82M | --14.69M | ---- | -71.69%4.3M | ---- | ---- | ---- |
| Cash outflows from financing activities | 77.45%1.37B | 29,290.87%874.24M | 313.64%1.21B | 341.82%979.53M | 500.36%770.46M | --2.97M | 394.85%292.95M | 656.73%221.7M | 542.63%128.33M | ---- |
| Net cash flows from financing activities | -333.65%-802.67M | -146.30%-334.74M | 216.00%249.8M | 421.42%408.27M | 367.70%343.54M | --723.03M | -96.18%79.05M | 367.26%78.3M | -542.63%-128.33M | ---- |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -141.67%-1.28M | -163.35%-160.42K | -70.99%1.46M | 602.12%2.52M | 31,737.30%3.07M | 114.95%253.22K | 317.52%5.04M | 23.82%-501.82K | 98.85%-9.71K | -632.83%-1.69M |
| Net increase in cash and cash equivalents | -178.27%-330.76M | 2.34%60.66M | -272.73%-496.4M | 1.35%-517.23M | 163.22%422.59M | 109.36%59.28M | -110.60%-133.18M | -190.87%-524.29M | -2,443.97%-668.39M | -2,296.53%-633.48M |
| Add:Begin period cash and cash equivalents | -36.92%848.19M | -36.92%848.19M | -9.01%1.34B | -9.01%1.34B | -9.01%1.34B | -9.01%1.34B | 566.86%1.48B | 566.86%1.48B | 566.86%1.48B | 566.86%1.48B |
| End period cash equivalent | -70.72%517.43M | -35.26%908.86M | -36.92%848.19M | -13.23%827.36M | 118.34%1.77B | 66.28%1.4B | -9.01%1.34B | 2,205.68%953.48M | 223.60%809.38M | 332.59%844.29M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- |
| Auditor | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg